The shareholders of LIDDS AB (publ), reg. no. 556580-2856, (the “Company” or “Lidds”), are hereby invited to attend the Annual General Meeting, as well as the first Control Meeting, on Wednesday, 28 May 2025 at 10 a.m. at Excore’s premises at Kungsportsavenyen 22, 411 36 Gothenburg.
Right to participate and notice to attend the meeting
Shareholders who are recorded in the share register kept by Euroclear Sweden AB (The Swedish Central Securities Depository Euroclear Sweden AB) as of 20 May 2025 and who have notified the Company of their intention to attend so that the notification is received by the Company no later than 22 May 2025 are entitled to participate in the meeting. The notification shall be sent to LIDDS AB (publ), Kungsportsavenyen 22, 411 36 Gothenburg. The notification may also be submitted electronically and shall then be sent to: info@liddspharma.com.
The notification shall state the full name, personal identification number or company registration number, shareholding, address, telephone number (daytime) and, where applicable, the number of assistants (maximum two). The notification should, where applicable, be accompanied by a power of attorney, certificate of registration, and other authorisation documents.
Nominee-registered shares
To be entitled to participate in the Annual General Meeting, shareholders who have had their shares registered with a nominee must temporarily re-register the shares in their own name. Shareholders who wish to re-register their voting rights must notify its trustee well in advance before 22 May 2025. The re-registration must be effected with Euroclear Sweden AB on 22 May 2025.
Proxy etc.
If shareholders are to be represented by a proxy, the proxy must bring a written and dated power of attorney signed by the shareholder to the meeting. The power of attorney must not be older than one year, unless a longer validity period (but no more than five years) is specified in the power of attorney. If the power of attorney is issued by a legal entity, the proxy must also bring a current registration certificate or equivalent authorization document for the legal entity. To facilitate entry at the meeting, a copy of the power of attorney and other authorisation documents should be attached to the notification of attendance at the Annual General Meeting. Power of attorney forms are available on the Company’s website www.liddspharma.com and will be sent by post to shareholders who contact the Company and state their address.
